Literature DB >> 18234004

High sensitivity CRP levels predict atrial tachyarrhythmias in rheumatic mitral stenosis.

Ekrem Ucer1, Baris Gungor, Izzet Celal Erdinler, Ahmet Akyol, Ahmet Taha Alper, Abdurrahman Eksik, Nazmiye Cakmak, Kadir Gurkan, Tanju Ulufer.   

Abstract

BACKGROUND: The different levels of inflammation in rheumatic mitral stenosis determine its clinical consequences. Atrial fibrillation is frequently encountered in mitral stenosis, though the independent role of chronic inflammation in determining atrial tachyarrhythmia occurrence in rheumatic heart disease has not been demonstrated previously.
METHODS: Measurements of C-reactive protein (CRP) with a high sensitivity assay to detect chronic inflammation were performed in a homogenous group of 50 patients with rheumatic mitral stenosis, who were in sinus rhythm. Patients were questioned to exclude confounders of CRP elevation. The patients underwent a twenty-four-hour ambulatory ECG monitoring to check for asymptomatic atrial tachyarrhythmias and were in addition classified according to the presence of atrial tachyarrhythmias.
RESULTS: Forty-four percent of patients showed a total of 100 episodes of atrial tachyarrhythmias where 63% of these episodes were paroxysmal atrial fibrillation. The CRP values in patients with tachyarrhythmias were significantly higher than in patients who remained in sinus rhythm (4.2 +/- 0.55 mg/L vs 1.99 +/- 0.36 mg/L, P < 0.001). A logistic regression analysis revealed only CRP levels and previous history of mitral valvuloplasty significantly determined tachyarrhythmia occurrence where age, left atrial volumes, mitral gradients had no statistically significant effect.
CONCLUSIONS: Our data implicated that nearly half of the mitral stenosis patients who are in sinus rhythm develop asymptomatic tachyarrhythmias and the higher levels of CRP in these patients show the significant effect of persistent inflammation on arrhythmia occurrence.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18234004      PMCID: PMC6932413          DOI: 10.1111/j.1542-474X.2007.00198.x

Source DB:  PubMed          Journal:  Ann Noninvasive Electrocardiol        ISSN: 1082-720X            Impact factor:   1.468


  25 in total

1.  PATIENTS WITH MITRAL STENOSIS AND SYSTEMIC EMBOLI; HEMODYNAMIC AND CLINICAL OBSERVATIONS.

Authors:  L CASELLA; W H ABELMANN; L B ELLIS
Journal:  Arch Intern Med       Date:  1964-12

2.  Increased levels of high sensitive C-reactive protein in patients with chronic rheumatic valve disease: evidence of ongoing inflammation.

Authors:  Zehra Gölbasi; Ozgül Uçar; Telat Keles; Ahmet Sahin; Kerim Cagli; Ahmet Camsari; Erdem Diker; Sinan Aydogdu
Journal:  Eur J Heart Fail       Date:  2002-10       Impact factor: 15.534

3.  Interaction of C-reactive protein complexes with the complement system. I. Consumption of human complement associated with the reaction of C-reactive protein with pneumococcal C-polysaccharide and with the choline phosphatides, lecithin and sphingomyelin.

Authors:  M H Kaplan; J E Volanakis
Journal:  J Immunol       Date:  1974-06       Impact factor: 5.422

4.  C-reactive protein elevation in patients with atrial arrhythmias: inflammatory mechanisms and persistence of atrial fibrillation.

Authors:  M K Chung; D O Martin; D Sprecher; O Wazni; A Kanderian; C A Carnes; J A Bauer; P J Tchou; M J Niebauer; A Natale; D R Van Wagoner
Journal:  Circulation       Date:  2001-12-11       Impact factor: 29.690

5.  Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events.

Authors:  Paul M Ridker; Nader Rifai; Lynda Rose; Julie E Buring; Nancy R Cook
Journal:  N Engl J Med       Date:  2002-11-14       Impact factor: 91.245

6.  [Effect of percutaneous transvenous mitral commissurotomy for the preservation of sinus rhythm in patients with mitral stenosis].

Authors:  S Abe; T Matsubara; T Hori; I Nakagawa; S Imai; K Ozaki; T Mezaki; A Nasuno; T Tanaka; Y Tamura; M Yamazoe; Y Aizawa
Journal:  J Cardiol       Date:  2001-07       Impact factor: 3.159

7.  Further evidence of inflammation in chronic rheumatic valve disease (CRVD): high levels of advanced oxidation protein products (AOPP) and high sensitive C-reactive protein (hs-CRP).

Authors:  Y Y Chiu-Braga; S Y Hayashi; M Schafranski; I J T Messias-Reason
Journal:  Int J Cardiol       Date:  2005-06-08       Impact factor: 4.164

8.  C-reactive protein elevation independently influences the procedural success of percutaneous balloon mitral valve commissurotomy.

Authors:  Richard A Krasuski; Anneke Bush; Joseph E Kay; Charles E Mayes; Andrew Wang; Judy Fleming; Cynthia Pierce; Katherine B Kisslo; J Kevin Harrison; Thomas M Bashore
Journal:  Am Heart J       Date:  2003-12       Impact factor: 4.749

9.  Influence of hormone replacement therapy on C-reactive protein: population-based data.

Authors:  Paola Primatesta; Emanuela Falaschetti; Neil R Poulter
Journal:  J Cardiovasc Risk       Date:  2003-02

10.  Interaction of C-reactive protein with artificial phosphatidylcholine bilayers.

Authors:  J E Volanakis; K W Wirtz
Journal:  Nature       Date:  1979-09-13       Impact factor: 49.962

View more
  6 in total

1.  Factors associated with the development of atrial fibrillation in patients with rheumatic mitral stenosis.

Authors:  Mehmet Ozaydin; Yasin Turker; Ercan Varol; Sule Alaca; Dogan Erdogan; Nigar Yilmaz; Abdullah Dogan
Journal:  Int J Cardiovasc Imaging       Date:  2010-03-24       Impact factor: 2.357

2.  Carotid intima media thickness and arterial stiffness in children with acute rheumatic fever.

Authors:  Murat Çiftel; Osman Yılmaz; Fırat Kardelen; Abdullah Kocabaş
Journal:  Pediatr Cardiol       Date:  2013-06-15       Impact factor: 1.655

3.  Study of the relation between serum levels of long-acting penicillin and the inflammatory markers: C-reactive protein and interleukin-6 in patients with chronic rheumatic heart disease.

Authors:  Ahmad M Yousef; Osama A Rifaie; Mohamed A Hamza; Sameh A Amin
Journal:  Egypt Heart J       Date:  2021-02-27

4.  Higher Copeptin Levels are Associated with the Risk of Atrial Fibrillation in Patients with Rheumatic Mitral Stenosis.

Authors:  Ilhan Ilker Avci; Irfan Sahin; Baris Gungor; Suat Hayri Kücük; Serhat Sigirci; Sinan Varol; Sevil Tugrul; Adem Atici; Orhan İnce; Ertugrul Okuyan
Journal:  Acta Cardiol Sin       Date:  2021-07       Impact factor: 2.672

5.  Association of inflammation with atrial fibrillation in hyperthyroidism.

Authors:  Mehmet Ozaydin; Ali Kutlucan; Yasin Turker; Banu Koroglu; Akif Arslan; Bayram A Uysal; Dogan Erdogan; Ercan Varol; Abdullah Dogan
Journal:  J Geriatr Cardiol       Date:  2012-12       Impact factor: 3.327

6.  The association of plasma high-sensitivity C-reactive protein level with rheumatic heart disease: The possible role of inflammation.

Authors:  Armin Attar; Parvin Marzban; Alireza Moaref; Kamran Aghasadeghi
Journal:  Indian Heart J       Date:  2017-08-26
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.